Mind Cure Health (MCUR.C) announced they have launched the second stage of manufacturing pharmaceutical grade ibogaine to be used in clinical research. MINDCURE will be assessing the quality of…
MCUR
Mind Cure (MCUR.C), a leader in advanced proprietary technology for psychedelic therapy, has provided updates regarding its financial position, near-term revenue strategy, and a timeline for iSTRYM’s market launch….
Mind Cure Health (MCUR.C) has entered into a partnership and licensing deal with SOMA Breath Inc. “We think it is important to give individuals options in building their mental…
Mind Cure (MCUR.C) has partnered with Lucid Inc. to design custom psychedelic music experiences for the Company’s iSTRYM technology. “We are building first-of-its-kind functionality by pairing AI-driven music scapes…
Mind Cure Health (MCUR.C) has entered into a partnership with Speak Ai to bolster the Company’s iSTRYM platform. “We are proud to partner with MINDCURE today to help build…
Mind Cure (MCUR.C) has filed a provisional patent application with the U.S. Patent and Trademark Office for the Company’s iSTRYM proprietary digital therapeutics (DTx) tool. “When people think of…
Mind Cure Health (MCUR.C) started their first stage of manufacturing pharma-grade ibogaine for both preclinical and clinical research today, according to a press release. Ibogaine is a psychoactive compound…
Mind Cure Health (MCUR.C) launched iSTRYM, a digital therapeutic tool for providing data regarding patient care, procedures and protocols, as well as other resources for mental health care workers…
Mind Cure Health (MCUR.C) released its latest formulation, an all-natural supplement called Mind Cure Teen today, according to a press release. Mind Cure Teen is intended to alleviate the…